Skip to content

Author

Wei Huang

We have 2 of 41 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Upfront surgery versus neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma in elderly patients: a multicenter cohort study

The optimal treatment strategy for elderly patients (aged ≥65 years) with operable locally advanced esophageal squamous cell carcinoma (ESCC) remains controversial. This study aimed to compare the survival outcomes of upfront surgery (US), neoadjuvant chemoimmunotherapy (nCIT), and neoadjuvant chemoradiotherapy (nC...

Z. Hou, Yi-Xiang Zhu, M. Lan et al. · 0 citations
Open access Sep 2026

Upfront or deferred radiotherapy combined with chemoimmunotherapy for inoperable oesophageal squamous cell carcinoma: a target trial emulation in China

Summary Background Radiotherapy (RT) is a curative treatment modality for inoperable oesophageal squamous cell carcinoma (ESCC). However, for patients with ESCC receiving first-line chemoimmunotherapy (CIT), the appropriate sequence of RT relative to CIT remains unclear. Methods This multicentre retrospective cohort st...

Hui-Quan Liu, Jia-Hao Guan, Wen-Cheng Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.